VACC - Vaccitech GAAP EPS of $0.41 revenue of $17.06M
- Vaccitech press release ( NASDAQ: VACC ): Q2 GAAP EPS of $0.41.
- License Revenue of $17.06M.
- As of June 30, 2022, cash and cash equivalents were $192.3 million, compared to $214.1 million as of December 31, 2021.
For further details see:
Vaccitech GAAP EPS of $0.41, revenue of $17.06M